🇺🇸 FDA
Patent

US 6979563

Attenuation of tumor growth, metastasis and angiogenesis

expired A61KA61K38/51

Quick answer

US patent 6979563 (Attenuation of tumor growth, metastasis and angiogenesis) held by BioMarin Enzymes, Inc. expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioMarin Enzymes, Inc.
Grant date
Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/51